[Skip to Content]
[Skip to Content Landing]
Other Articles
May 1, 1937


JAMA. 1937;108(18):1544-1545. doi:10.1001/jama.1937.02780180068017

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The Council on Pharmacy and Chemistry has issued a number of reports during the last few months indicative of its constant efforts to keep abreast of the newest therapeutic advances. The description of protamine zinc insulin, together with its actions and uses, was elaborated by the Council (The Journal, February 20, p. 640) in close cooperation with representatives of the Insulin Committee of the University of Toronto. The Council's report gives succinctly the essential attributes of the preparation.

Ingestion of the nonmetabolizable substance called mandelic acid imparts to the urine a sufficient degree of acidity to yield effective bactericidal action provided certain pathologic conditions are not present. The Council's report on this product (The Journal, March 27, p. 1033), prepared for the Council by Dr. William F. Braasch, informed the profession of the essential properties of mandelic acid therapy. However, the Council, with admirable caution, decided that the time was

First Page Preview View Large
First page PDF preview
First page PDF preview